{
  "ticker": "PRME",
  "company_name": "Prime Medicine, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT07226622",
      "title": "Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical Trial",
      "status": "RECRUITING",
      "phase": "",
      "condition": "Wilson Disease",
      "start_date": "2025-12",
      "completion_date": "2027-12",
      "enrollment": 0,
      "sponsor": "Prime Medicine, Inc."
    },
    {
      "nct_id": "NCT06559176",
      "title": "A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants With p47phox Autosomal Recessive Chronic Granulomatous Disease (CGD )",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Chronic Granulomatous Disease, Granulomatous Disease, Chronic",
      "start_date": "2024-10-17",
      "completion_date": "2030-02",
      "enrollment": 0,
      "sponsor": "Prime Medicine, Inc."
    }
  ],
  "summary": {
    "total_trials": 2,
    "by_phase": {
      "": 1,
      "PHASE1, PHASE2": 1
    },
    "by_status": {
      "RECRUITING": 1,
      "ACTIVE_NOT_RECRUITING": 1
    },
    "active_trials": 2,
    "completed_trials": 0,
    "conditions": [
      "Chronic Granulomatous Disease, Granulomatous Disease, Chronic",
      "Wilson Disease"
    ],
    "lead_stage": "unknown"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:21:00.229936",
    "search_query": "Prime Medicine, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Prime+Medicine,+Inc."
  }
}